In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy (original) (raw)
References
Akira S . (2000). Oncogene, 19, 2607–2611.
Bielinska A, Shivdasani RA, Zhang LQ and Nabel GJ . (1990). Science, 250, 997–1000.
Bishop-Bailey D and Hla T . (1999). J. Biol. Chem., 274, 17042–17048.
Boccaccio C, Ando M, Tamagnone L, Bardelli A, Michieli P, Battistini C and Comoglio PM . (1998). Nature, 391, 285–288.
Bowman T, Broome MA, Sinibaldi D, Wharton W, Pledger WJ, Sedivy JM, Irby R, Yeatman T, Courtneidge SA and Jove R . (2001). Proc. Natl. Acad. Sci. USA, 98, 7319–7324.
Bowman T, Garcia R, Turkson J and Jove R . (2000). Oncogene, 19, 2474–2488.
Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE . (1999). Cell, 98, 295–303.
Catlett-Falcone R, Dalton WS and Jove R . (1999a). Curr. Opin. Oncol., 11, 490–496.
Catlett-Falcone R, Landowski TH, Oshiro MM, Turkson J, Levitzki A, Savino R, Ciliberto G, Moscinski L, Fernandez-Luna JL, Nunez G, Dalton WS and Jove R . (1999b). Immunity, 10, 105–115.
Darnell Jr JE . (1997). Science, 277, 1630–1635.
Folkman J . (1997). Exs, 79, 1–8.
Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW and Bridges AJ . (1994). Science, 265, 1093–1095.
Garcia R, Bowman TL, Niu G, Yu H, Minton S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, Laudano A, Gazit A, Levitzki A, Kraker A and Jove R . (2001). Oncogene, 20, 2499–2513.
Gouilleux-Gruart V, Gouilleux F, Desaint C, Claisse JF, Capiod JC, Delobel J, Weber-Nordt R, Dusanter-Fourt I, Dreyfus F, Groner B and Prin L . (1996). Blood, 87, 1692–1697.
Grandis JR, Drenning SD, Zeng Q, Watkins SC, Melhem MF, Endo S, Johnson DE, Huang L, He Y and Kim JD . (2000a). Proc. Natl. Acad. Sci. USA, 97, 4227–4232.
Grandis JR, Melhem MF, Gooding WE, Day R, Holst VA, Wagener MM, Drenning SD and Tweardy DJ . (1998). J. Natl. Cancer Inst., 90, 824–832.
Grunstein J, Roberts WG, Mathieu-Costello O, Hanahan D and Johnson RS . (1999). Cancer Res., 59, 1592–1598.
Hanahan D and Folkman J . (1996). Cell, 86, 353–364.
Hanahan D and Weinberg RA . (2000). Cell, 100, 57–70.
Huang M, Page C, Reynolds RK and Lin J . (2000). Gynecol Oncol, 79, 67–73.
Kawamura I, Morishita R, Tomita N, Lacey E, Aketa M, Tsujimoto S, Manda T, Tomoi M, Kida I, Higaki J, Kaneda Y, Shimomura K and Ogihara T . (1999). Gene Therapy, 6, 91–97.
Kraker AJ, Hartl BG, Amar AM, Barvian MR, Showalter HD and Moore CW . (2000). Biochem. Pharmacol., 60, 885–898.
Leong PL, Andrews GA, Johnson DE, Dyer KF, Xi S, Mai JC, Robbins PD, Gadiparthi S, Burke NA, Watkins SF and Grandis JR . (2003). Proc. Natl. Acad. Sci. USA, 100, 4138–4143.
Levy DE and Darnell Jr JE . (2002). Nat. Rev. Mol. Cell. Biol., 3, 651–662.
Li L and Shaw PE . (2002). J. Biol. Chem., 277, 17397–17405.
Lim R, Zaheer A, Yorek MA, Darby CJ and Oberley LW . (2000). J. Neurochem., 74, 596–602.
Mann MJ and Dzau VJ . (2000). J. Clin. Invest., 106, 1071–1075.
Mayer F, Honecker F, Looijenga LH and Bokemeyer C . (2003). Ann. Oncol., 14, 825–832.
Millauer B, Shawver LK, Plate KH, Risau W and Ullrich A . (1994). Nature, 367, 576–579.
Nabel EG, Plautz G and Nabel GJ . (1990). Science, 249, 1285–1288.
Nakajima K, Yamanaka Y, Nakae K, Kojima H, Ichiba M, Kiuchi N, Kitaoka T, Fukada T, Hibi M and Hirano T . (1996). EMBO J., 15, 3651–3658.
Nielsen M, Kaestel CG, Eriksen KW, Woetmann A, Stokkedal T, Kaltoft K, Geisler C, Ropke C and Odum N . (1999). Leukemia, 13, 735–738.
Niu G, Heller R, Catlett-Falcone R, Coppola D, Jaroszeski M, Dalton W, Jove R and Yu H . (1999). Cancer Res., 59, 5059–5063.
Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R and Yu H . (2002). Oncogene, 21, 2000–2008.
Park SH, Liu X, Hennighausen L, Davey HW and Waxman DJ . (1999). J. Biol. Chem., 274, 7421–7430.
Plate KH, Breier G, Weich HA and Risau W . (1992). Nature, 359, 845–848.
Rak J, Mitsuhashi Y, Sheehan C, Tamir A, Viloria-Petit A, Filmus J, Mansour SJ, Ahn NG and Kerbel RS . (2000). Cancer Res., 60, 490–498.
Takeda T, Kurachi H, Yamamoto T, Homma H, Morishige K, Miyake A and Murata Y . (1997). J. Endocrinol., 153, R1–3.
Takeuchi S, Imafuku I, Waragai M, Roth C, Kanazawa I, Buettner R, Mouradian MM and Okazawa H . (1999). Brain Res. Mol. Brain Res., 74, 208–216.
Turkson J, Bowman T, Adnane J, Zhang Y, Djeu JY, Sekharam M, Frank DA, Holzman LB, Wu J, Sebti S and Jove R . (1999). Mol. Cell. Biol., 19, 7519–7528.
Turkson J, Ryan D, Kim JS, Zhang Y, Chen Z, Haura E, Laudano A, Sebti S, Hamilton AD and Jove R . (2001). J. Biol. Chem., 276, 45443–45455.
Veikkola T and Alitalo K . (1999). Semin. Cancer Biol., 9, 211–220.
Veikkola T, Karkkainen M, Claesson-Welsh L and Alitalo K . (2000). Cancer Res., 60, 203–212.
von Knethen A, Lotero A and Brune B . (1998). Oncogene, 17, 387–394.
Wagner BJ, Hayes TE, Hoban CJ and Cochran BH . (1990). EMBO J., 9, 4477–4484.
Wang LH, Yang XY, Kirken RA, Resau JH and Farrar WL . (2000). Blood, 95, 1249–1257.
Wei D, Le X, Zheng L, Wang L, Frey JA, Gao AC, Peng Z, Huang S, Xiong HQ, Abbruzzese JL and Xie K . (2003). Oncogene, 22, 319–329.
Wong P, Severns CW, Guyer NB and Wright TM . (1994). Mol. Cell. Biol., 14, 914–922.
Xi S, Zhang Q, Dyer KF, Lerner EC, Smithgall TE, Gooding WE, Kamens J and Grandis JR . (2003). J. Biol. Chem., 278, 31574–31583.
Yu CL, Meyer DJ, Campbell GS, Larner AC, Carter-Su C, Schwartz J and Jove R . (1995). Science, 269, 81–83.